Invesaro

Stocks Health care XXII

NASDAQ · Health care

22nd Century Group, Inc. (XXII)

22nd Century Group, Inc. brought in $14.5M of revenue over the twelve months to June 30, 2026, down 27.4% from a year earlier. It posted a net loss of $3.9M. In fiscal 2025 capital spending exceeded operating cash flow by $7.8M. At June 30, 2026 it held $6.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Free, no password. An email when XXII files with the SEC.

Price
$1.48
+4.23% on the day · November 11, 2026
52-week range $1.40 to $21,489.00
Market cap
$1.1M
Revenue (last 12 months)
$14.5M
-27.4% year on year
Net margin
-27.0%

Key facts about 22nd Century Group, Inc.

Net worth
22nd Century Group, Inc. has a market value (market cap) of $1.1M at the latest share price, and shareholders' equity of $18.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $17.6M (-27.9% year on year), with a net loss of $5.1M. Over the 12 months to June 30, 2026: revenue $14.5M, net loss $3.9M.
Cash flow
In fiscal 2025 operations used $7.7M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
22nd Century Group, Inc.'s next report was expected around November 3, 2026 and is not on file with the SEC yet.

What 22nd Century Group, Inc. does

22nd Century Group, Inc. is registered with the SEC under industry code SIC 2111 (Cigarettes). Its shares trade on NASDAQ under the ticker XXII.

Revenue and profit by year

Revenue
FY18: $26.4M $26.4M FY18FY19: $25.8M $25.8M FY19FY20: $28.1M $28.1M FY20FY21: $30.9M $30.9M FY21FY22: $40.5M $40.5M FY22FY23: $32.2M $32.2M FY23FY24: $24.4M $24.4M FY24FY25: $17.6M $17.6M FY25
Net income
FY18: -$8M -$8M FY18FY19: -$26.6M -$26.6M FY19FY20: -$19.7M -$19.7M FY20FY21: -$32.6M -$32.6M FY21FY22: -$59.8M -$59.8M FY22FY23: -$140.8M -$140.8M FY23FY24: -$15.2M -$15.2M FY24FY25: -$5.1M -$5.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$17.6M-$11.6M-$5.1M-$52.87-$7.8M
2024$24.4M-$14M-$15.2M-$45,711.05-$14.5M
2023$32.2M-$44.9M-$140.8M-$4,136,563.02-$59.6M
2022$40.5M-$33.6M-$59.8M-$2,642,172.81-$55.4M
2021$30.9M-$28.4M-$32.6M-$1,789,859.00-$23.6M
2020$28.1M-$19.2M-$19.7M-$1,193,239.33-$15.7M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

A report was expected around November 3, 2026 and is not on file yet.

Estimated from its filing rhythm: 52 weeks after its report of November 4, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where XXII ranks in Health care

Revenue$17.6M
#484 of 751 in Health care · Bottom 36%
Revenue growth-27.9%
#500 of 532 in Health care · Bottom 6%
Net margin-28.7%
#350 of 544 in Health care · Bottom 36%
Free cash flow margin-44.3%
#369 of 490 in Health care · Bottom 25%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What 22nd Century Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 1, 2026
  2. August 25, 2026
  3. August 20, 2026
  4. August 20, 2026
  5. August 14, 2026
  6. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 30% to $2.9M versus the same quarter last year; diluted EPS -$104.00 versus -$3,390.05.
  7. August 14, 2026
  8. August 13, 2026
  9. August 5, 2026
  10. July 2, 2026

Recent insider filings (Forms 3, 4 and 144): 9, the latest on November 14, 2025. Insider transactions on SEC

Insider trades

What the people running 22nd Century Group, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns XXII

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Joseph Reda13G, passive with 1 related filers 9.97% 71,256 August 20, 2026
Richard Abbe13G, passive with 2 related filers 9.9% 70,824 August 25, 2026
Schechter Jonathan13G, passive 9.9% 71,256 August 20, 2026
Anson Funds Management LP13G, passive with 5 related filers 6.7% 34,565 August 14, 2026

Latest filings below 5%: Gregory Castaldo 0% (February 13, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

8 insiders reported holding 253,286 shares in total, about $374.9K at the last price.

HolderSharesAs of
Firestone LawrenceChief Executive Officer, Director 68,129 November 10, 2025
Otto Daniel AChief Financial Officer 37,871 November 10, 2025
Staffeldt JonathanVP and Deputy General Counsel 37,871 November 10, 2025
Marion Arvil S.VP of Mfg. Operations* 33,062 November 10, 2025
Manfredonia Robert PEVP of Sales and Marketing 33,062 November 10, 2025
Arno AndrewDirector 17,481 November 10, 2025
Keys David NDirector 14,696 November 10, 2025
Salhany Lucille SDirector 11,114 November 10, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about XXII

What does 22nd Century Group, Inc. do?

22nd Century Group, Inc. is a company in the Health care sector, listed on NASDAQ as XXII. Its shares trade on NASDAQ under the ticker XXII.

What is 22nd Century Group, Inc.'s net worth?

22nd Century Group, Inc. has a market value (market cap) of $1.1M at the latest share price, and shareholders' equity of $18.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is 22nd Century Group, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $3.9M on revenue of $14.5M.

How much revenue does 22nd Century Group, Inc. make?

Over the twelve months to June 30, 2026 22nd Century Group, Inc. reported revenue of $14.5M. That is 27.4% less than a year earlier.

When did 22nd Century Group, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 1, 2026.

When is 22nd Century Group, Inc.'s next earnings report?

22nd Century Group, Inc.'s next report was expected around November 3, 2026 and is not on file with the SEC yet.

Similar companies

Compare XXII with

Compare XXII with any company

Follow XXII

Get an email when 22nd Century Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when XXII files with the SEC.

Where the numbers come from

Financial figures are the values 22nd Century Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.